Location: Cambridge, MA
CIK: 0001917529 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 13, 2025
Total Value: $753M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | 4,896,462 | $277M | 36.8% | $58.25 | -22.6% | Common Stock | 501575104 |
| IRON | Disc Medicine, Inc. | 2,142,617 | $142M | 18.8% | $48.39 | +22.9% | Common Stock | 254604101 |
| DYN | Dyne Therapeutics, Inc. | 9,130,465 | $116M | 15.3% | $13.88 | -17.8% | Common Stock | 26818M108 |
| SION | Sionna Therapeutics, Inc. | 3,615,527 | $106M | 14.1% | $16.34 | +33.1% | Common Stock | 829401108 |
| KRRO | Korro Bio, Inc. | 1,137,149 | $54.46M | 7.2% | $33.30 | -33.4% | Common Stock | 500946108 |
| DAWN | Day One Biopharmaceuticals, Inc. | 6,430,257 | $45.33M | 6.0% | $19.68 | -65.0% | Common Stock | 23954D109 |
| — | Generation Bio, Co. | 827,946 | $5.067M | 0.7% | $7.08 | — | Common Stock | 37148K100 |
| QTTB | Q32 Bio, Inc. | 2,092,106 | $4.142M | 0.6% | $13.78 | -86.1% | Common Stock | 746964105 |
| IMA | ImageneBio, Inc. | 377,814 | $3.079M | 0.4% | $13.25 | 0.0% | Common Stock | 45175G207 |